Octreotide treatment of massive hemorrhage due to cytomegalovirus colitis

Canadian Journal of Gastroenterology

Volumn 17, Issue 12, 2003, Pages 722-725

  Andrews, Christopher N ^a   Beck, Paul L ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

CMV; Colitis; Cytomegalovirus; Octreotide

Indexed keywords

ANTINEOPLASTIC AGENT; GANCICLOVIR; OCTREOTIDE;

ABDOMINAL PAIN; ADULT; ARTICLE; B CELL LEUKEMIA; BLOOD TRANSFUSION; CASE REPORT; CECUM; CLINICAL FEATURE; COLITIS; COLONOSCOPY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG TOLERABILITY; FEMALE; HEMATOCHEZIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHATIC LEUKEMIA; PRIORITY JOURNAL;

EID: 0346025613     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/915731     Document Type: Article

References (38)

1. Page MJ, Dreese JC, Poritz LS, Koltun WA. Cytomegalovirus; enteritis: A highly lethal condition requiring early detection and intervention. Dis Colon Rectum 1998;41:619-23.
2. Kaufman HS, Kahn AC, Iacobuzio-Donahue C, Talamini MA, Lillemoe KD, Hamilton SR. Cytomegaloviral enterocolitis: Clinical associations and outcome. Dis Colon Rectum 1999;42:24-30.
3. Bini EJ, Weinshel EH, Falkenstein DB. Risk factors for recurrent bleeding and mortality in human immunodeficiency virus infected patients with acute lower GI hemorrhage. Gastrointest Endosc 1999;49:748-53.
4. Chetty R, Roskell DE. Cytomegalovirus infection in the gastrointestinal tract. J Clin Pathol 1994;47:968-72.
5. Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993; 119:924-35.
6. Keates J, Lagahee S, Crilley P, Haber M, Kowalski T. CMV enteritis causing segmental ischemia and massive intestinal hemorrhage. Gastrointest Endosc 2001;53:355-9.
7. Sun JH, Johnson WS, Bascom JF. Cytomegalovirus-induced massive small intestinal bleed. Case report and review of the literature. Rev Med Chir Soc Med Nat Iasi 1997;101:209-12.
8. Chalasani N, Wilcox CM. Etiology and outcome of lower gastrointestinal bleeding in patients with AIDS. Am J Gastroenterol 1998;93:175-8.
9. Leung SF, Lee KC, Lam HW, Gastro-intestinal cytomegalovirus infection and extensive colonic ulceration in a renal transplant recipient. Hong Kong Med J 1998;4:434-6.
10. Zhang HB, Wong BC, Zhou XM, et al. Effects of somatostatin, octreotide and pitressin plus nitroglycerine on systemic and portal haemodynamics in the control of acute variceal bleeding. Int J Clin Pract 2002;56:447-51.
11. Banares R, Albillos A, Rincon D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis. Hepatology 2002;35:609-15.
12. Jenkins SA, Taylor BA, Nott DM, Ellenbogen S, Haggie J, Shields R. Management of massive upper gastrointestinal haemorrhage from multiple sites of peptic ulceration with somatostatin and octreotide - A report of five cases. Gut 1992;33:404-7.
13. Imperiale TF, Birgisson S. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis. Ann Intern Med 1997;127:1062-71.
14. Nardone G, Rocco A, Balzano T, Budillon G. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999;13:1429-36.
15. Zhou Y, Qiao L, Wu J, Hu H, Xu C. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: A controlled study. J Gastroenterol Hepatol 2002;17:973-9.
16. Yoshie K, Fujita Y, Moriya A, Kawana I, Miyamoto K, Umemura S. Octreotide for severe acute bleeding from portal hypertensive colopathy: A case report. Eur J Gastroenterol Hepatol 2001;13:1111-3.
17. Garcia N, Sanyal AJ. Portal hypertensive gastropathy and gastric antral vascular ectasia. Curr Treat Options Gastroenterol 2001;4:163-71.
18. Gonzalez D, Elizondo BJ, Haslag S, et al. Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome. J Pediatr Gastroenterol Nutr 2001;33:183-8.
19. Heuser M, Popken O, Kleiman I, Post S. Detrimental effects of octreotide on intestinal microcirculation. J Surg Res 2000;92:186-92.
20. Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Miccini M. [Effects of octreotide (somatostatin analog SMS 201-995) on superior mesenteric artery blood flow in swine. An experimental study using Doppler color ultrasonography]. G Chit 1999;20:9-13.
21. Kubba AK, Dallal H, Haydon GH, Hayes PC, Palmer KR. The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man. Am J Gastroenterol 1999;94:1077-82.
22. McCormick PA, Seifalian AM, Stansby G, et al. Superior mesenteric artery blood flow in man measured with intra-arterial Doppler catheters: Effect of octreotide. J Hepatol 1993;17:20-7.
23. Schiedermaier P, Brensing KA, Goke B, Schatzle T, Sauerbruch T. Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers. Digestion 1999;60:132-40.
24. Nevens F, Van Steenbergen W, Yap SH, Fevery J. Assessment of variceal pressure by continuous non-invasive endoscopic registration: A placebo controlled evaluation of the effect of terlipressin and octreotide. Gut 1996;38:129-34.
25. McCormick PA, Chin J, Greenslade L, et al. Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology 1995;21:1255-60.
26. Lin HC, Tsai YT, Lee FY, et al. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 1992;103:229-34.
27. Chan LY, Sung JJ. Review article: The role of pharmaco-therapy for acute variceal haemorrhage in the era of endoscopic haemostasis. Aliment Pharmacol Ther 1997;11:45-50.
28. Turkcapar N, Bayar S, Koyuncu A, Ceyhan K. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice. Hepatogastroenterology 2003;50:680-3.
29. Aldemir M, Kokoglu OF, Geyik MF, Buyukbayram H. Effects of octreotide acetate and Saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats. Tohoku J Exp Med 2002;198:1-9.
30. Akyildiz M, Ersin S, Oymaci E, Dayangac M, Kapkac M, Alkanat M. Effects of somatostatin analogues and vitamin C on bacterial translocation in an experimental intestinal obstruction model of rats. J Invest Surg 2000;13:169-73.
31. Taylor GE, Hebra A, McGowan KL, et al. Octreotide does not prevent bacterial translocation in an infant piglet model of intestinal ischemia-reperfusion. J Pediatr Surg 1995;30:967-70.
32. Turkcapar AG, Ersoz S, Gut U, et al. The effect of octreotide on bacterial translocation from the gut. An experimental study. Int Surg 1995;80:264-6.
33. Wallace JL, Boichot E, Sidoti C, Brecx A, Paubert-Braquet M. Protective effects of somatostatin against gastric damage induced by hemorrhagic shock, stress and PAF in the rat. Regul Pept 1993;47:195-203.
34. Kusterer K, Buchheit KH, Schade A, et al. The somatostatin analogue octreotide protects against ethanol-induced microcirculatory stasis and elevated vascular permeability in rat gastric mucosa. Eur J Pharmacol 1994;259:265-71.
35. Gines A, Salmeron JM, Gines P, et al. Effects of somatostatin on renal function in cirrhosis. Gastroenterology 1992;103:1868-74.
36. John KD, Ballantyne GH, Modlin IM. Octreotide acetate inhibits motility in the rabbit distal colon. Eur Surg Res 1997;29:311-8.
37. Morris JB, Guerrero NH, Furth EE, Stellato TA. Somatostatin attenuates ischemic intestinal injury. Am J Surg 1993;165:676-80.
38. Anderson SH, Dalton HR. Use of octreotide in the treatment of mesenteric angina. Am J Gastroenterol 1997;92:1222-3.